presentations​

03 APR 2017

Opthea Phase 1/2A wet AMD Trial Update Presentation, Webcast 10.30am Monday 3 April AEST (8.30pm US EST Sunday April 2)

view the webcast >>
09 JAN 2017

Opthea Corporate Presentation during JPMorgan Conference in San Francisco

read more >>
12 SEP 2016

A first-in-human Phase 1/2a study of the novel VEGF-C/D inhibitor OPT-302 alone and in combination with ranibizumab in patients with wet AMD

read more >>
09 AUG 2016

Opthea presentation for the Ophthalmology Innovation Summit in San Francisco

read more >>
25 JUL 2016

Opthea Conference Call: Update on Ph1 Wet AMD Clinical Trial. Date: Tuesday, July 26, 10:30am Australian Eastern Standard Time. (Monday, July 25, 8:30pm US EST)

view the webcast >>
07 MAR 2016

CEO Presentation for the EGM

read more >>
11 JAN 2016

Opthea Presentation to Biotech Showcase San Francisco

read more >>
30 NOV 2015

CEO presentation for the Annual General Meeting

read more >>
13 NOV 2015

Circadian/Opthea presentation at OIS 2015

read more >>
09 JUL 2015

Circadian Corporate Presentation – July 2015

read more >>
02 JUN 2015

Circadian partner Eli Lilly presents IMC-3C5 Ph1 at ASCO

read more >>
07 May 2015

ARVO 2015 Conference: OPT-302 in wet AMD

read more >>
14 Apr 2015

World Congress on Angiogenesis 2015: Poster

read more >>
15 Feb 2015

Circadian Investor Presentation - February 2015

read more >>
18 Nov 2014

CEO Address: Annual General Meeting: Nov 18 2014

read more >>
06 Oct 2014

Circadian Investor Presentation - Oct 6 2014

read more >>
10 Jan 2013

Company Presentation at JP Morgan Biotech Showcase

read more >>
20 Nov 2012

CEO AGM Presentation to shareholders

read more >>
07 Jul 2012

Bio 2012 - Building a Diagnostics Franchise

read more >>
12 Jan 2012

CEO Presentation at Biotech Showcase San Francisco

read more >>
24 Nov 2011

Annual General Meeting Presentation 24 November 2011

read more >>
11 Oct 2011

Biopartnering Europe Presentation

read more >>
07 Sep 2011

Circadian Corporate Presentation - Septemeber 2011

read more >>
16 Jun 2011

Circadian provides market update on clinical development plans for VGX-100 in oncology and eye disease indications

read more >>
11 Nov 2010

2010 AGM Managing Director's Presentation

read more >>
03 Aug 2010

Australian Microcap Investment Conference Presentation

read more >>
28 Jun 2010

Corporate Presentation

read more >>
24 Mar 2010

Corporate Presentation

read more >>
19 Nov 2009

2009 AGM Managing Director's Presentation

read more >>
10 Nov 2009

Merriman Presentation

read more >>
09 Jul 2009

Corporate Presentation

read more >>
13 May 2009

FINSIA Presentation

read more >>
24 Apr 2009

BioMelbourne Network Presentation

read more >>
26 Mar 2009

Corporate Presentation

read more >>
14 Nov 2008

Managing Director's AGM Presentation

read more >>
21 Oct 2008

Corporate Presentation

read more >>
16 Oct 2008

Wilson HTM Life Sciences Showcase

read more >>